{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:20:09Z","timestamp":1781533209090,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.humpath.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T12:35:24Z","timestamp":1529670924000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinicopathological analysis of immunohistochemical expression of retinoic acid\u2013related orphan receptor-\u03b3t in peripheral T-cell lymphoma, not otherwise specified"],"prefix":"10.1016","volume":"79","author":[{"given":"Eriko","family":"Yanagida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-3725","authenticated-orcid":false,"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiji","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nagafuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.05.002_bb0005","series-title":"World Health Organisation classification of tumors of haematopoietic and lymphoid tissues","first-page":"403","article-title":"Peripheral T-cell lymphoma, not otherwise specified","author":"Pileri","year":"2017"},{"key":"10.1016\/j.humpath.2018.05.002_bb0010","series-title":"World Health Organisation classification of tumors of haematopoietic and lymphoid tissues","first-page":"306","article-title":"Peripheral T-cell lymphoma, not otherwise specified","author":"Pileri","year":"2008"},{"key":"10.1016\/j.humpath.2018.05.002_bb0015","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International T-cell lymphoma project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0020","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2018.05.002_bb0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.humpath.2018.05.002_bb0030","doi-asserted-by":"crossref","first-page":"63261","DOI":"10.18632\/oncotarget.11211","article-title":"ROR\u03b1 and ROR\u03b3 expression inversely correlates with human melanoma progression","volume":"7","author":"Bro\u017cyna","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.05.002_bb0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1245\/s10434-015-4923-3","article-title":"A high ROR\u03b3T\/CD3 ratio is a strong prognostic factor for postoperative survival in advanced colorectal cancer: analysis of helper T cell lymphocytes (Th1, Th2, Th17 and regulatory T cells)","volume":"23","author":"Yoshida","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1309\/AJCP0SBHYVLY5EML","article-title":"Expression of master regulators of helper T-cell differentiation in peripheral T-cell lymphoma, not otherwise specified, by immunohistochemical analysis","volume":"133","author":"Matsumoto","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imr.12248","article-title":"Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications","volume":"263","author":"Inghirami","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.humpath.2018.05.002_bb0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jcp.2010.084459","article-title":"Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases","volume":"64","author":"Zhan","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0055","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.2008.25","article-title":"The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma","volume":"21","author":"Karube","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0060","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Lymphoma leukemia molecular profiling project and the international peripheral T-cell lymphoma project. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.05.002_bb0065","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","article-title":"GATA-3 expression identifies a high-risk subset of PTCL-NOS with distinct molecular and clinical features","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.05.002_bb0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/ejh.12856","article-title":"Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified","volume":"98","author":"Kawamoto","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0075","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00428-017-2233-9","article-title":"Clinicopathological analysis in PTCL-NOS with CADM1 expression","volume":"471","author":"Kato","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2018.05.002_bb0080","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1309\/AJCPBPNV86VZENGV","article-title":"Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders","volume":"137","author":"Miyoshi","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0085","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","article-title":"Understanding diagnostic tests 3: receiver operating characteristic curves","volume":"96","author":"Akobeng","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.humpath.2018.05.002_bb0090","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1158\/1078-0432.CCR-16-0434","article-title":"Prognostic value of programmed death ligand 1 and programmed death 1 expression in thymic carcinoma","volume":"22","author":"Yokoyama","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.05.002_bb0095","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.05.002_bb0100","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","article-title":"Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification","volume":"15","author":"Savage","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0105","first-page":"901","article-title":"High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORgamma","volume":"62","author":"Ueda","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2018.05.002_bb0110","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1096\/fj.13-242040","article-title":"ROR\u03b1 and ROR\u03b3 are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D","volume":"28","author":"Slominski","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.humpath.2018.05.002_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","article-title":"Interleukin-6: from basic science to medicine-40 years in immunology","volume":"23","author":"Kishimoto","year":"2005","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0125","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/eji.201142250","article-title":"Overexpression of ROR\u03b3t under control of the CD2 promoter induces polyclonal plasmacytosis and autoantibody production in transgenic mice","volume":"42","author":"Yoh","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0130","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.144.2.574","article-title":"A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes","volume":"144","author":"Anderson","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2018.05.002_bb0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature10075","article-title":"Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand","volume":"472","author":"Solt","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2018.05.002_bb0140","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature09978","article-title":"Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing ROR\u03b3t activity","volume":"472","author":"Huh","year":"2011","journal-title":"Nature"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681771830159X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681771830159X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T09:09:54Z","timestamp":1693732194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681771830159X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":28,"alternative-id":["S004681771830159X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.05.002","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological analysis of immunohistochemical expression of retinoic acid\u2013related orphan receptor-\u03b3t in peripheral T-cell lymphoma, not otherwise specified","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}